Valentine Charlton-Menys

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Helen M. Colhoun, D. J. Betteridge, Paul N. Durrington et al. · The Lancet · 2004 · 3.8K citations

Metabolic Syndrome, Primary Prevention, Diabetes Management +8

Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis

Robert K. Semple, Alison Sleigh, Peter R. Murgatroyd et al. · Journal of Clinical Investigation · 2009 · 334 citations · Full text

Immunology, Pathology, Insulin Receptor Gene +22

Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)

Helen M. Colhoun, D. J. Betteridge, Paul N. Durrington et al. · American Journal of Kidney Diseases · 2009 · 252 citations

Metabolic Syndrome, Hemodialysis, Urology +11

Sequencing of the Reannotated LMNB2 Gene Reveals Novel Mutations in Patients with Acquired Partial Lipodystrophy

Robert A. Hegele, Henian Cao, Dora M. Liu et al. · The American Journal of Human Genetics · 2006 · 196 citations · Full text

Metabolic Syndrome, Lipid Synthesis, Genetic Disorder +7

Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes

Helen M. Colhoun, D. J. Betteridge, Paul N. Durrington et al. · Diabetes · 2011 · 160 citations · Full text